Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Omar Niss

Showing results (21-30 of 39) with videos related to

Pageof 4
Sort By:
Blood Cells, Molecules & Diseases|September 27, 2016
Genotype-phenotype correlations in hereditary elliptocytosis and hereditary pyropoikilocytosisOmar Niss, Satheesh Chonat, Neha Dagaonkar, et al.
American Journal of Hematology|May 21, 2019
Robust clinical and laboratory response to hydroxyurea using pharmacokinetically guided dosing for young children with sickle cell anemiaPatrick T McGann, Omar Niss, Min Dong, et al.
Scientific Reports|February 6, 2020
Left atrial dysfunction in sickle cell anemia is associated with diffuse myocardial fibrosis, increased right ventricular pressure and reduced exercise capacityTarek Alsaied, Omar Niss, Justin T Tretter, et al.
Scientific Reports|March 14, 2020
Author Correction: Left atrial dysfunction in sickle cell anemia is associated with diffuse myocardial fibrosis, increased right ventricular pressure and reduced exercise capacityTarek Alsaied, Omar Niss, Justin T Tretter, et al.
Cardiology in the Young|April 7, 2020
Lymphopenia in adults after the Fontan operation: prevalence and associationsTarek Alsaied, Mathias Possner, Nicole Brown, et al.
British Journal of Haematology|July 6, 2021
Early initiation of hydroxyurea (hydroxycarbamide) using individualised, pharmacokinetics-guided dosing can produce sustained and nearly pancellular expression of fetal haemoglobin in children with sickle cell anaemiaCharles T Quinn, Omar Niss, Min Dong, et al.
Blood Cells, Molecules & Diseases|January 5, 2021
Congenital dyserythropoietic anemia type I: First report from the Congenital Dyserythropoietic Anemia Registry of North America (CDAR)Omar Niss, Robert B Lorsbach, Mikaela Berger, et al.
Health Care Transitions|June 1, 2026
Community health worker support to adolescents and young adults with sickle cell disease: A multi-method analysis on transition-related supportJayanne Forrest, Claudio Galea, Caren Steinway, et al.
JAMA Network Open|November 17, 2025
Community Health Worker and Mobile Health Interventions for Quality of Life Among Young Adults With Sickle Cell Disease: A Randomized Clinical TrialSophia Jan, Caren Steinway, Tanisha Belton, et al.
Frontiers in Physiology|July 24, 2019
The Spectrum of <i>SPTA1</i>-Associated Hereditary SpherocytosisSatheesh Chonat, Mary Risinger, Haripriya Sakthivel, et al.
Pageof 4

Showing results (21-30 of 39) with videos related to

Sort By:
Pageof 4
Blood Cells, Molecules & Diseases|September 27, 2016
Genotype-phenotype correlations in hereditary elliptocytosis and hereditary pyropoikilocytosisOmar Niss, Satheesh Chonat, Neha Dagaonkar, et al.
American Journal of Hematology|May 21, 2019
Robust clinical and laboratory response to hydroxyurea using pharmacokinetically guided dosing for young children with sickle cell anemiaPatrick T McGann, Omar Niss, Min Dong, et al.
Scientific Reports|February 6, 2020
Left atrial dysfunction in sickle cell anemia is associated with diffuse myocardial fibrosis, increased right ventricular pressure and reduced exercise capacityTarek Alsaied, Omar Niss, Justin T Tretter, et al.
Scientific Reports|March 14, 2020
Author Correction: Left atrial dysfunction in sickle cell anemia is associated with diffuse myocardial fibrosis, increased right ventricular pressure and reduced exercise capacityTarek Alsaied, Omar Niss, Justin T Tretter, et al.
Cardiology in the Young|April 7, 2020
Lymphopenia in adults after the Fontan operation: prevalence and associationsTarek Alsaied, Mathias Possner, Nicole Brown, et al.
British Journal of Haematology|July 6, 2021
Early initiation of hydroxyurea (hydroxycarbamide) using individualised, pharmacokinetics-guided dosing can produce sustained and nearly pancellular expression of fetal haemoglobin in children with sickle cell anaemiaCharles T Quinn, Omar Niss, Min Dong, et al.
Blood Cells, Molecules & Diseases|January 5, 2021
Congenital dyserythropoietic anemia type I: First report from the Congenital Dyserythropoietic Anemia Registry of North America (CDAR)Omar Niss, Robert B Lorsbach, Mikaela Berger, et al.
Health Care Transitions|June 1, 2026
Community health worker support to adolescents and young adults with sickle cell disease: A multi-method analysis on transition-related supportJayanne Forrest, Claudio Galea, Caren Steinway, et al.
JAMA Network Open|November 17, 2025
Community Health Worker and Mobile Health Interventions for Quality of Life Among Young Adults With Sickle Cell Disease: A Randomized Clinical TrialSophia Jan, Caren Steinway, Tanisha Belton, et al.
Frontiers in Physiology|July 24, 2019
The Spectrum of <i>SPTA1</i>-Associated Hereditary SpherocytosisSatheesh Chonat, Mary Risinger, Haripriya Sakthivel, et al.
Pageof 4